GLP-1 Market
LLY $1145.46 ▼ -1.0% NVO $37.49 ▼ -1.1% PFE $28.29 ▼ -0.8% VKTX $31.28 ▼ -4.0% KLRA $10.77 ▼ -5.7% GPCR $30.27 ▼ -3.2% RHHBY $51.91 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

G-Pump™

Company
Xeris Pharmaceuticals
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Oct 1, 2026

Trial details
  • Completed NCT NCT02081001

    PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients

    Not yet reported Xeris Pharmaceuticals 19 participants Est. completion 2014-09 1 site
    Other conditions: Hypoglycemia
    View official trial listing →
  • Status unknown NCT NCT02489669

    Renal Insufficiency Following Contrast Media Administration Trial III

    Not yet reported Clinica Mediterranea 700 participants Est. completion 2019-12
    Other conditions: Contrast Nephropathy
    View official trial listing →
  • Completed NCT NCT02733588

    Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

    Not yet reported Xeris Pharmaceuticals 8 participants Est. completion 2017-06-01 1 site
    Other conditions: Hypoglycemia, Complications of Bariatric Procedures
    View official trial listing →
  • Enrolling by invitation NCT NCT07568405

    The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold

    Not yet reported Université Libre de Bruxelles 40 participants Est. completion 2026-06-15 1 site
    Other conditions: Pain Threshold, Surgery, Postoperative Pain, Intravenous Anesthesia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: G-Pump™, G-Pump™ (glucagon infusion)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.